CStone Pharmaceuticals
CSPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $388 | $997 | $559 | $743 |
| Short-Term Investments | $285 | $52 | $483 | $984 |
| Receivables | $131 | $172 | $77 | $118 |
| Inventory | $286 | $109 | $22 | $61 |
| Other Curr. Assets | $0 | $0 | $106 | $52 |
| Total Curr. Assets | $1,090 | $1,330 | $1,247 | $1,958 |
| Property Plant & Equip (Net) | $131 | $153 | $207 | $188 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $161 | $173 | $160 | $71 |
| Long-Term Investments | -$276 | $4 | -$480 | -$980 |
| Tax Assets | $0 | $0 | $480 | $0 |
| Other NC Assets | $288 | $2 | $25 | $1,036 |
| Total NC Assets | $304 | $332 | $392 | $314 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,393 | $1,662 | $1,638 | $2,271 |
| Liabilities | – | – | – | – |
| Payables | $338 | $246 | $290 | $414 |
| Short-Term Debt | $93 | $139 | $45 | $44 |
| Tax Payable | $2 | $18 | $6 | $24 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $249 | $447 | $605 | $450 |
| Total Curr. Liab. | $682 | $850 | $946 | $933 |
| LT Debt | $263 | $224 | $241 | $130 |
| Deferred Rev, NC | $85 | $62 | $1 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | -$1 |
| Other NC Liab. | $0 | $69 | $0 | $1 |
| Total NC Liab. | $348 | $355 | $243 | $131 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $38 | $44 | $59 | $28 |
| Total Liabilities | $1,030 | $1,205 | $1,189 | $1,064 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$9,111 | -$9,020 | -$8,652 | -$7,750 |
| AOCI | $470 | $483 | $473 | $491 |
| Other Equity | $9,004 | $8,992 | $8,628 | $8,465 |
| Total Equity | $364 | $457 | $449 | $1,207 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,393 | $1,662 | $1,638 | $2,271 |
| Net Debt | -$32 | -$633 | -$272 | -$569 |